Saint-Gobain Launches Zero® Filter Capsule to Maximize Bioprocess Yield
News related to:Saint-Gobain Bioprocess Solutions · 2 min read
MALVERN, Pa., Oct. 22, 2026 /CourierPR/ -- Saint-Gobain Bioprocess Solutions has unveiled a groundbreaking filtration technology designed to maximize bioprocess yield by virtually eliminating unrecoverable fluid volume. The new Zero® Filter Capsule, introduced in 1.5-inch and 2.5-inch mid-size formats, promises to revolutionize the efficiency of biopharmaceutical manufacturing by recovering product that would otherwise be lost during filtration.
The traditional capsule filters used in bioprocessing retain significant amounts of valuable fluid within their internal dead spaces and core voids. This unrecoverable volume can lead to substantial losses, particularly in larger-scale applications, where the impact on overall process yield can be considerable. According to the press release, the Zero® Filter Capsule reduces unrecoverable volume to near zero, setting a new standard for yield and operational economics.
The key to this breakthrough is the patented aseptic recovery technology integrated directly into the filter architecture. Upon completion of the filtration process, sterile gas is directed into the filter core, actively displacing and recovering product that would otherwise remain trapped downstream. This recovery process ensures that every milliliter of drug product reaches its intended destination, significantly reducing waste and maximizing the value of each batch.
Hannah Hertrick, Market Development Manager of Filtration Products at Saint-Gobain Bioprocess Solutions, emphasized the importance of this innovation.
The launch of the Zero® Filter Capsule is part of Saint-Gobain Bioprocess Solutions' broader strategy to improve process efficiency through innovative single-use technologies. The company is developing a range of solutions that address efficiency both around the process and within it, reflecting its commitment to helping manufacturers improve productivity while advancing sustainability objectives.
The 1.5-inch and 2.5-inch Zero® Filter Capsules are now available for immediate sampling, process validation, and commercial order. Additional formats designed to support larger-scale bioprocessing applications are in development and will be rolled out as part of the ongoing expansion of the Zero® product line.
Saint-Gobain Bioprocess Solutions partners with biopharmaceutical manufacturers to solve complex process challenges through innovative single-use technologies. From high-performance vent filtration that can reduce footprint and simplify system integration to low-holdup liquid filtration designed to improve product recovery, the company is dedicated to improving process efficiency and maximizing product value.
The launch of the Zero® Filter Capsule marks a significant step forward in bioprocessing technology, offering manufacturers a practical solution to reduce waste and enhance yield. As the biopharmaceutical industry continues to evolve, Saint-Gobain Bioprocess Solutions is poised to play a crucial role in driving innovation and efficiency in the field.